Latest news with #Scott+Scott
Business Wire
3 days ago
- Business
- Business Wire
KOHL'S INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Kohl's Corporation's Directors and Officers for Breach of Fiduciary Duties
NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international securities and consumer rights litigation firm, is investigating whether the leadership of Kohl's Corporation ('Kohl's') (NYSE: KSS), breached their fiduciary duties to Kohl's and its shareholders. Scott+Scott is investigating whether members of the Kohl's board of directors or senior management failed to manage Kohl's in an acceptable manner, in breach of their fiduciary duties to Kohl's, and whether Kohl's and its shareholders have suffered damages as a result. On May 1, 2025, Kohl's announced it had fired its CEO for funneling contracts with Kohl's to his romantic partner for above their fair market value. What You Can Do – If you own shares of Kohl's, you may have legal claims against directors and officers of Kohl's. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@ About Us Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations. With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit Attorney Advertising
Business Wire
3 days ago
- Business
- Business Wire
MOBILEYE GLOBAL INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Mobileye Global Inc.'s Directors and Officers for Breach of Fiduciary Duties
NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international securities and consumer rights litigation firm, is investigating whether Intel Corporation ('Intel'), as well as the leadership of Mobileye Global Inc. ('Mobileye') (NASDAQ: MBLY), breached their fiduciary duties to Mobileye and its shareholders. Scott+Scott is investigating whether Intel, as controlling stockholder of Mobileye, as well as members of the Mobileye board of directors or senior management, failed to manage Mobileye in an acceptable manner, or enriched themselves at Mobileye's expense, in breach of their fiduciary duties to Mobileye, and whether Mobileye and its shareholders have suffered damages as a result. On January 4, 2024, Mobileye announced that it had 'become aware' of an accumulation of excess inventory with its customers, that 'lower-than-expected volumes' in the EyeQ area of its business would temporarily affect profitability and lowered its revenue guidance for 2024 accordingly. On August 1, 2024, Mobileye announced it was further reducing its 2024 revenue guidance, with the channel stuffing issue as the cause. On this news, Mobileye stock fell to $16.28/share. In June 2023, Intel, the controlling stockholder of Mobileye, sold 38.5 million shares of Mobileye at $42/share, getting over $1.6 billion in proceeds. What You Can Do – If you own shares of Mobileye, you may have legal claims against Intel, as well as Mobileye's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@ About Us Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations. With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit Attorney Advertising
Business Wire
6 days ago
- Business
- Business Wire
CAPITAL ONE FINANCIAL INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Capital One Financial Corporation's Directors and Officers for Breach of Fiduciary Duties
NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international securities and consumer rights litigation firm, is investigating whether the leadership of Capital One Financial Corporation ('Capital One') (NYSE: COF) breached their fiduciary duties to Capital One and its shareholders. Scott+Scott is investigating whether members of the Capital One board of directors or senior management failed to manage Capital One in an acceptable manner, in breach of their fiduciary duties to Capital One, and whether Capital One and its shareholders have suffered damages as a result. On May 16, 2025, Capital One disclosed in a federal court filing that it had agreed to pay $425 million to settle a proposed class action lawsuit which alleges that Capital One deceptively advertised its 360 Savings accounts as high-interest products. What You Can Do – If you own shares of Capital One, you may have legal claims against Capital One's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@ About Us Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations. With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit Attorney Advertising
Associated Press
18-04-2025
- Business
- Associated Press
Scott+Scott Attorneys at Law LLP Reminds Investors that It is Investigating Ibotta, Inc. (NYSE: IBTA)
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), a shareholder and consumer rights litigation firm, is investigating whether Ibotta, Inc. ('Ibotta' or the 'Company') (NYSE: IBTA) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Ibotta is a technology company that allows consumer packaged goods brands to deliver digital promotions to consumers through a single network called the Ibotta Performance Network. On April 18, 2024, Ibotta issued 6,560,700 shares of Class A common stock at $88 per share in an initial public offering. On February 26, 2025, after market hours, Ibotta issued a press release containing its financial results for fourth quarter 2024 and full year 2024, respectively. The press release revealed quarterly revenue of $98.4 million, representing a 1% year-over-year decline. The press release also revealed a first quarter 2025 revenue outlook ranging from $80 million to $84 million, reflecting a 0% year-over-year increase at the midpoint. On this news, the price of Ibotta shares declined by $29.08 per share, or approximately 46%, from $63.09 per share on February 26, 2025, to close at $34.01 on February 27, 2025, on heavy trading volume. ARE YOU A POTENTIAL CLASS MEMBER ELIGIBLE TO RECOVER? CLICK HERE If you have purchased Ibotta Class A common stock, and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected]. CLICK HERE TO FIND OUT IF YOU CAN RECOVER YOUR LOSSES About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. This may be considered Attorney Advertising. CONTACT: Nicholas Bruno Scott+Scott Attorneys at Law LLP 230 Park Avenue, 24th Floor, New York, NY 10169 (888) 398-9312 [email protected]
Associated Press
11-04-2025
- Business
- Associated Press
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. ('Treace Medical' or the 'Company') (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, 'Defendants'). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired Treace Medical securities between May 8, 2023, and May 7, 2024, inclusive (the 'Class Period'), and were damaged thereby (the 'Class'). The Class Action filed by Scott+Scott is captioned: McCluney v. Treace Medical Concepts, Inc., et al., Case No. 3:25-cv-00390. LEAD PLAINTIFF DEADLINE ON JUNE 10, 2025 Treace Medical is a medical technology company focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. The Company has patented the Lapiplasty, a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System (the 'Lapiplasty'); (2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and (3) Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. As the truth about Treace Medical's business reached the market, the price of Treace Medical's stock suffered significant declines, harming investors. For example, on May 7, 2024, after market hours, when the Company issued a press release reporting, among other things, that it lowered its full-year 2024 revenue guidance from between $220 million and $225 million to between $201 million and $211 million. During the associated earnings call the same day, Defendants revealed competition from minimally invasive osteotomy and Lapiplasty 'knockoffs' created headwinds for Lapiplasty growth. On this news, the Company's stock price fell $6.95, or nearly 63%, to close at $4.17 per share on May 8, 2024, on unusually high trading volume. LEAD PLAINTIFF DEADLINE ON JUNE 10, 2025 If you purchased Treace Medical securities during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Middle District of Florida no later than June 10, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected]. What You Can Do? You may contact an attorney to discuss your rights regarding the appointment of lead plaintiff or your interest in the Class Action. You may retain counsel of your choice to represent you in the Class Action. About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit This may be considered Attorney Advertising. CONTACT: Nicholas S. Bruno Scott+Scott Attorneys at Law LLP 230 Park Avenue, 24th Floor, New York, NY 10169 (888) 398-9312 [email protected]
